we are approaching (yet another) binary event not unlike when...

we are approaching (yet another) binary event not unlike when other biotechs are ready to report on their crucial Phase 2/3 results from drug trial.....there are a lot of investors who may be a strong supporters of the company but who will not sit through those announcements and will sell out just before....hence the sp drop - imho...

sitting through those crucial dates is very very risky as nothing is given and every unexpected thing may happen...

said that my parcel is not large so I am quite happy to sit through that and persevere till the approval is finally granted...

I was holding through couple binary events in my other bios and both had the most disastrous outcomes....one I exit right after taking a loss the second I am sitting put for various reasons one being my loses are too large to take them bravely "on the chin" PLUS I know the drug is good and will get to market one day....

GL to all whatever you decide doing at this stage.....